Registry of CLH intentions until outcome
Registry of CLH intentions until outcome
Registry of CLH intentions until outcome
The registry of classification and labelling (CLH) intentions until outcome lists the intentions and proposals received by ECHA for a new or revised harmonised classification and labelling of a substance. The proposals are submitted by Member State competent authorities, manufacturers, importers or downstream users.
Interested parties can follow the progress of a proposal through the CLH process, from the notification of the intention to the adoption of the opinion of the Committee for Risk Assessment (RAC). The advance notice enables interested parties to plan and prepare for commenting later on.
Anyone with relevant information on the identity or hazard properties of a substance is encouraged to provide this information to the dossier submitter during the early stages of the process, or at the latest during the consultation.
Where an opinion has been adopted by RAC, the status is indicated as ‘Opinion Adopted’.
Note: The classification tables for those substances that have been reviewed are listed in the ‘Corrigenda to the RAC opinions’ document.
1,3-diphenylguanidine
EC / List no: 203-002-1 CAS no: 102-06-7CLP Annex VI Index number | 612-149-00-4 |
Further substance information | |
Status | Opinion Development |
Date of intention | 05-lip-2019 |
Expected date of submission | 30-ruj-2023 |
Submitted for accordance check | 08-ruj-2023 |
Final submission date | 04-ožu-2024 |
Withdrawal date | |
Legal deadline for opinion adoption | 03-ruj-2025 |
Submitter | France |
Submitter's email | classification.clp@anses.fr |
Harmonised classification at the time of the proposal | Acute Tox. 4*, H302 Skin Irrit. 2, H315 Eye Irrit. 2, H319 Repr. 2, H361f*** STOT SE 3, H335 Aquatic Chronic 2, H411 |
Specific concentration limits at the time of the proposal | |
Proposed harmonised classification by the dossier submitter | Acute Tox. 3, H301 Skin Irrit. 2, H315 Eye Dam. 1, H318 Skin Sens. 1A, H317 Repr. 1B, H360FD STOT SE 3, H335 STOT RE 2, H373 Aquatic Chronic 3, H412 |
Proposed specific concentration limits by the dossier submitter | H373 (nervous system) Oral: ATE=110 mg/kg |
Regulatory programme | Chemical registered under REACH |
Remarks | |
Start of consultation | 18-ožu-2024 |
Deadline for commenting | 17-svi-2024 |
Hazard classes open for commenting | Reproductive toxicity Acute Toxicity - oral Specific target organ toxicity – repeated exposure Serious eye damage/eye irritation Skin Sensitisation Hazardous to the aquatic environment |
CLH report | |
Annexes to the CLH report | |
Date of opinion | |
RAC Opinion | |
Background document | |
RCOM (Comments received) | |
Attachments received during consultation (excluding journal articles) | |
Minority opinion(s) | |
Other annexes | |
ATP number and date | |
Link to ATP | |
Latest update | 25-lip-2024 |
First published | 02-srp-2019 |